Publications by authors named "Anna Smed-Sorensen"

Background: Genetics influence the clinical picture in sarcoidosis, a granulomatous heterogeneous disease often accompanied by elevated serum angiotensin converting enzyme (s-ACE). We aimed to investigate if certain HLA-DRB1 alleles correlate with the levels of s-ACE, known as a marker of the granuloma burden.

Methods: Medical journals of patients with sarcoidosis from a Swedish clinical registry were retrospectively examined to extract the highest recorded s-ACE value and analysed in relation to patient characteristics including phenotype [Löfgren syndrome (LS)/ non-LS], chest X-ray staging according to Scadding, treatment with immunosuppressants, presence of extrapulmonary manifestations (EPM), HLA-DRB1 alleles and prognosis (resolving vs.

View Article and Find Full Text PDF

Background: Sarcoidosis is an immune-mediated inflammatory disease whose natural development is not well understood. We aimed to determine if inflammatory plasma protein levels are elevated before sarcoidosis diagnosis compared to controls. Furthermore, we investigated which proteins are increased and how long before diagnosis they are increased.

View Article and Find Full Text PDF

We previously demonstrated that the lungs of deceased COVID-19 patients were filled with a clear hydrogel consisting of hyaluronan (HA). In this translational study, we investigated the role of HA at all stages of COVID-19 disease to map the consequences of elevated HA on morbidity and identify the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced HA production. A reduced alveolar surface area was observed in the lungs of deceased COVID-19 patients compared to healthy controls, as visualized by a 3D rendering of lung morphology using light-sheet fluorescence microscopy.

View Article and Find Full Text PDF

Native banana lectin (BanLec) is antiviral but highly mitogenic, which limits its therapeutic value. In contrast, the genetically engineered H84T BanLec (H84T) is not mitogenic but remains effective against influenza A virus (IAV) infection in mouse models. However, the potency and effect of H84T on human immune cells and IAV-specific immune responses is undetermined.

View Article and Find Full Text PDF

Hantaviruses cause the acute zoonotic diseases hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). Infected patients show strong systemic inflammation and immune cell activation. NK cells are highly activated in HFRS, suggesting that also other innate lymphoid cells (ILCs) might be responding to infection.

View Article and Find Full Text PDF

Sarcoidosis is a granulomatous multiorgan disease, thought to result from exposure to yet unidentified antigens in genetically susceptible individuals. The exaggerated inflammatory response that leads to granuloma formation is highly complex and involves the innate and adaptive immune system. Consecutive immunological studies using advanced technology have increased our understanding of aberrantly activated immune cells, mediators and pathways that influence the formation, maintenance and resolution of granulomas.

View Article and Find Full Text PDF

Introduction: Several novel vaccine platforms aim at mucosal immunity in the respiratory tract to block SARS-CoV-2 transmission. Standardized methods for mucosal sample collection and quantification of mucosal antibodies are therefore urgently needed for harmonized comparisons and interpretations across mucosal vaccine trials and real-world data.

Methods: Using commercial electrochemiluminescence antibody panels, we compared SARS-CoV-2 spike-specific IgA and IgG in paired saliva, nasal secretions, and serum from 1048 healthcare workers with and without prior infection.

View Article and Find Full Text PDF
Article Synopsis
  • * This study aimed to develop and validate a new baseline proteomic signature, analyzing over 7000 proteins from patients to predict the severity of COVID-19 during infection.
  • * The findings indicated that 4110 proteins showed significant differences between mild and severe cases, with a promising predictive accuracy, identifying five key proteins and age as indicators for disease severity.
View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on how SARS-CoV-2 interacts with human cells, using a new super-resolution proximity labeling (SR-PL) technique to analyze the virus's ORF3a and membrane proteins, revealing significant changes in endoplasmic reticulum structures.
  • - Researchers identified 224 and 272 unique peptides associated with ORF3a and membrane proteins, respectively, highlighting the role of RNF5, which modifies ORF3a and aids in its degradation.
  • - The study found that increasing RNF5 levels in host cells can significantly lower the infection rate of SARS-CoV-2, and the findings are accessible online to aid further research on virus-host interactions.
View Article and Find Full Text PDF
Article Synopsis
  • * In a study of blood samples, researchers found that as COVID-19 severity increases, the number of SARS-CoV-2-specific circulating Tfh (cTfh) cells also increases, correlating with higher antibody levels and better plasmablast differentiation.
  • * However, in patients who experience severe COVID-19, the development of effective cTfh cells is delayed, leading to slower production of high-quality antibodies, which may contribute to the progression of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • - Vaccination provides significant protection against severe COVID-19 variants like omicron but is less effective at preventing initial infections; a study of 368 triple vaccinated healthcare workers observed a 22% infection rate among participants.
  • - High serum antibody levels were linked to better protection against infection, as indicated by a lower viral load and quicker viral clearance in qPCR positive cases.
  • - Previous infection with non-omicron variants improves protection against omicron, mainly through mucosal spike-specific IgA responses, while only 10% of those infected remained asymptomatic.
View Article and Find Full Text PDF

During respiratory viral infections, the precise roles of monocytes and dendritic cells (DCs) in the nasopharynx in limiting infection and influencing disease severity are incompletely described. We studied circulating and nasopharyngeal monocytes and DCs in healthy controls (HCs) and in patients with mild to moderate infections (primarily influenza A virus [IAV]). As compared to HCs, patients with acute IAV infection displayed reduced DC but increased intermediate monocytes frequencies in blood, and an accumulation of most monocyte and DC subsets in the nasopharynx.

View Article and Find Full Text PDF

Since the beginning of the SARS-CoV-2 pandemic in 2020, researchers worldwide have made efforts to understand the mechanisms behind the varying range of COVID-19 disease severity. Since the respiratory tract is the site of infection, and immune cells differ depending on their anatomical location, studying blood is not sufficient to understand the full immunopathogenesis in patients with COVID-19. It is becoming increasingly clear that monocytes, dendritic cells (DCs), and monocytic myeloid-derived suppressor cells (M-MDSCs) are involved in the immunopathology of COVID-19 and may play important roles in determining disease severity.

View Article and Find Full Text PDF

Mitochondria are the main consumers of oxygen within the cell. How mitochondria sense oxygen levels remains unknown. Here we show an oxygen-sensitive regulation of TFAM, an activator of mitochondrial transcription and replication, whose alteration is linked to tumours arising in the von Hippel-Lindau syndrome.

View Article and Find Full Text PDF

Respiratory viral infections with SARS-CoV-2 and influenza viruses commonly induce a strong infiltration of immune cells into the human lung, with potential detrimental effects on the integrity of the lung tissue. Despite comprising the largest fractions of circulating lymphocytes in the lung, rather little is known about how peripheral blood natural killer (NK) cell and T cell subsets are equipped for lung-homing in COVID-19 and influenza. Here, we provide a detailed comparative analysis of NK cells and T cells in patients infected with SARS-CoV-2 or influenza virus, focusing on the protein and gene expression of chemokine receptors known to be involved in recruitment to the lung.

View Article and Find Full Text PDF

Understanding the presence and durability of antibodies against SARS-CoV-2 in the airways is required to provide insights into the ability of individuals to neutralize the virus locally and prevent viral spread. Here, we longitudinally assessed both systemic and airway immune responses upon SARS-CoV-2 infection in a clinically well-characterized cohort of 147 infected individuals representing the full spectrum of COVID-19 severity, from asymptomatic infection to fatal disease. In addition, we evaluated how SARS-CoV-2 vaccination influenced the antibody responses in a subset of these individuals during convalescence as compared with naive individuals.

View Article and Find Full Text PDF

Sarcoidosis is a systemic inflammatory disease mainly affecting the lungs. The hallmark of sarcoidosis are granulomas that are surrounded by activated T cells, likely targeting the disease-inducing antigen. IFNγ-producing Th1 and Th17.

View Article and Find Full Text PDF